Log in to save to my catalogue

Therapeutic Drug Monitoring of Quinidine in Pediatric Patients with IKCNT1/I Genetic Variants

Therapeutic Drug Monitoring of Quinidine in Pediatric Patients with IKCNT1/I Genetic Variants

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A746374156

Therapeutic Drug Monitoring of Quinidine in Pediatric Patients with IKCNT1/I Genetic Variants

About this item

Full title

Therapeutic Drug Monitoring of Quinidine in Pediatric Patients with IKCNT1/I Genetic Variants

Publisher

MDPI AG

Journal title

Pharmaceutics, 2022-10, Vol.14 (10)

Language

English

Formats

Publication information

Publisher

MDPI AG

More information

Scope and Contents

Contents

Quinidine (QND) is an old antimalarial drug that was used in the early 20th century as an antiarrhythmic agent. Currently, QND is receiving attention for its use in epilepsy of infancy with migrating focal seizures (EIMFS) due to potassium sodium-activated channel subfamily T member 1 (KCNT1) genetic variants. Here, we report the application of The...

Alternative Titles

Full title

Therapeutic Drug Monitoring of Quinidine in Pediatric Patients with IKCNT1/I Genetic Variants

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A746374156

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A746374156

Other Identifiers

ISSN

1999-4923

E-ISSN

1999-4923

DOI

10.3390/pharmaceutics14102230

How to access this item